Sociocultural dimensions of tuberculosis: An overview of key concepts

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 10, 2015, Pages 1135-1143

  Mason, P H ^a   Degeling, C ^b   Denholm, J ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Gender; Social determinants; Stigma; Surveillance; Syndemics

Indexed keywords

ARTICLE; COMMUNITY STRUCTURE; CULTURAL ANTHROPOLOGY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH CARE DISPARITY; HELP SEEKING BEHAVIOR; HISTORY OF MEDICINE; HUMAN; INFECTION CONTROL; INTERPERSONAL COMMUNICATION; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SOCIOLOGY; NONHUMAN; PRIORITY JOURNAL; RESPONSIBILITY; RISK ASSESSMENT; SEX DIFFERENCE; SOCIAL INTERACTION; SOCIAL PARTICIPATION; TUBERCULOSIS; CULTURAL FACTOR; INTERDISCIPLINARY COMMUNICATION; ORGANIZATION AND MANAGEMENT; PERSONNEL; PROCEDURES; PSYCHOLOGY; RESEARCH; SOCIOLOGY; STEREOTYPING;

ANTHROPOLOGY, CULTURAL; CROSS-CULTURAL COMPARISON; HUMANS; INTERDISCIPLINARY COMMUNICATION; RESEARCH; RESEARCH PERSONNEL; SOCIAL SCIENCES; STEREOTYPING; TUBERCULOSIS;

EID: 84942755202     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0066     Document Type: Article

References (90)

1. Cronje G. Tuberculosis and mortality decline in England and Wales, 1851-1919. In: Woods R, Woodward J. eds. Urban disease and mortality in nineteenth century England. New York, NY, USA: St Martin's Press, 1984; 79-101.
2. Caldwell M. The last crusade: the war on consumption, 1862-1954. New York, NY, USA: Atheneum, 1988.
3. Smith F B. The retreat of tuberculosis, 1850-1950. London, UK: Croom Helm, 1988.
4. Mesa J M. Historia de la tuberculosis en Espana, 1889-1936. Granada, Spain: University of Granada, 1989. [Spanish]
5. Bates B. Bargaining for life: a social history of tuberculosis, 1876-1938, Philadelphia, PA, USA: University of Pennsylvania Press, 1992.
6. Armus D. The ailing city: health, tuberculosis, and culture in Buenos Aires, 1870-1950. Durham, NC, USA and London, UK: Duke University Press, 2011.
7. Arnold M. Disease, class and social change: tuberculosis in Folkestone and Sandgate, 1880-1930. Newcastle upon Tyne, UK: Cambridge Scholars Publishing, 2012.
8. Styblo K. The number of cases of tuberculosis throughout the world has increased over the last 30 years. WHO/IUAT Information Kit. Geneva, Switzerland: WHO, 1982.
9. Fairchild A L, Oppenheimer G M. Public health nihilism vs pragmatism: history, politics, and the control of tuberculosis. Am J Public Health 1998; 88: 1105-1117.
10. Waaler H T. Tuberculosis in the world. Bull Int Union Tuberc Lung Dis 1982; 57(3-4): 202-205.
11. Ali M. Treating tuberculosis as a social disease. Lancet 2014; 383: 2195.
12. Raviglione M, Krech R. Tuberculosis: still a social disease [Editorial]. Int J Tuberc Lung Dis 2011; 15 (Suppl 2): S6-S8.
13. World Health Organization. WHO Sixty-Seventh World Health Assembly. Global strategy and targets for tuberculosis prevention, care and control after 2015. A67/11. Geneva, Switzerland: WHO, 2014.
14. Isaakidis P, Smith S, Majumdar S, Furin J, Reid T. Calling tuberculosis a social disease-an excuse for complacency? Lancet 2014; 384: 1095.
15. Dubos R J, Dubos J. The white plague: tuberculosis, man, and society. Boston, MA, USA: Little Brown, 1952.
16. Sutherland H. The soil and the seed in tuberculosis. BMJ 1912; 2: 1434-1437.
17. Engel N, Pai M. Tuberculosis diagnostics: why we need more qualitative research. J Epidemiol Global Health 2013; 3: 119-121.
18. Pai N P, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low-and middle-income countries. PLOS MED 2012; 9: e1001306.
19. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32-38.
20. Rose G. The strategy of preventative medicine. Oxford, UK: Oxford University Press, 1992.
21. Rosenberg C E. Explaining epidemics: and other studies in the history of medicine. Cambridge, UK: Cambridge University Press, 1992.
22. Bareja C, Waring J, Stapledon R. Tuberculosis notifications in Australia, 2010. Commun Dis Intell 2014; 38: 36-48.
23. Clarke A E, Shim J K, Mamo L, Fosket J R, Fishman J R. Biomedicalization: technoscientific transformations of health, illness, and US biomedicine. Am Sociol Rev 2003; 68: 161-194.
24. Horner J, Wood J G, Kelly A. Public health in/as 'national security': tuberculosis and the contemporary regime of border control in Australia. Crit Public Health 2013; 23: 418-431.
25. Reitmanova S, Gustafson D L. Coloring the white plague: a syndemic approach to immigrant tuberculosis in Canada. Ethn Health 2012; 17: 403-418.
26. Möller M, De Wit E, Hoal E G. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010; 58: 3-26.
27. Cantwell M F, McKenna M T, McCray E, Onorato I M. Tuberculosis and race/ethnicity in the United States: impact of socio-economic status. Am J Respir Crit Care Med 1998; 157: 1016-1020.
28. Serpa J A, Teeter L D, Musser J M, Graviss E A. Tuberculosis disparity between US-born blacks and whites, Houston, Texas, USA. Emerg Infect Dis 2009; 15: 899.
29. Galtung J. Cultural violence. J Peace Res 1990; 27: 291-305.
30. Anderson W. The third-world body. In: Cooter R, Pickstone J V, eds. Companion to medicine in the twentieth century. London, UK: Routledge, 1990: pp 235-245.
31. Farmer P. An anthropology of structural violence. Curr Anthropol 2004; 45: 305-325.
32. Green L. The utter normalization of violence: silence, memory and impunity among the Yup'ik people of Southwestern Alaska. In: Six-Hohenbalken N, Weiss N, eds. Violence expressed: an anthropological approach. Farnham, UK: Ashgate Publishing Limited, 2011: pp 21-36.
33. Green L. To die in the silence of history: tuberculosis epidemics and Yup'ik peoples of Southwestern Alaska. In: Barber P G, Leach B, Lem W, eds. Confronting capital: critique and engagement in anthropology. New York, NY, USA: Routledge, 2012: pp 97-112.
34. Seeberg J. The death of Shankar: social exclusion and tuberculosis in a poor neighbourhood in Bhubaneswar, Odisha. In: Skoda U, Nielsen K B, Fibiger M Q, eds. Navigating social exclusion and inclusion in contemporary India and beyond: structures, agents, practices. Anthem Press, 2013: pp 207-226.
35. Singer M. Introduction to syndemics: a critical systems approach to public and community health. San Francisco, CA, USA: Jossey-Bass, 2009.
36. Lock M. Encounters with aging: mythologies of menopause in Japan and North America. Berkeley, CA, USA: University of California Press, 1993.
37. Koch E. Local microbiologies of tuberculosis: insights from the Republic of Georgia. Med Anthropol 2011; 30: 81-101.
38. Koch E. Tuberculosis is a threshold: the making of a social disease in post-Soviet Georgia. Med Anthropol 2013; 32: 309-324.
39. Denholm J T, McBryde E S, Brown G V. Ethical evaluation of immigration screening policy for latent tuberculosis infection. Aust N Z J Public Health 2012; 36: 325-328.
40. Kehr J. Blind spots and adverse conditions of care: screening migrants for tuberculosis in France and Germany. Sociol Health Illn 2012; 34: 251-265.
41. Warren A. (Re)locating the border: pre-entry tuberculosis (TB) screening of migrants to the UK. Geoforum 2013; 48: 156-164.
42. Welshman J, Bashford A. Tuberculosis, migration, and medical examination: lessons from history. J Epidemiol Community Health 2006; 60: 282-284.
43. Fox G J, Barry S E, Britton W J, Marks G B. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013; 41: 140-156.
44. Shah N S, Yuen C M, Heo M, Tolman AW, Becerra M C. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 2014; 58: 381-391.
45. Sintchenko V, Gilbert G L. Utility of genotyping of Mycobacterium tuberculosis in the contact investigation: a decision analysis. Tuberculosis 2007; 87: 176-184.
46. Sintchenko V, Iredell J R, Gilbert G L. Pathogen profiling for disease management and surveillance. Nat Rev Microbiol 2007; 5, 464-470.
47. Gallego B, Sintchenko V, Jelfs P, Coiera E, Gilbert G G. Three-year longitudinal study of genotypes of Mycobacterium tuberculosis in a low prevalence population. Pathology 2010; 42: 267-272.
48. Harper I. Anthropology, DOTS and understanding tuberculosis control in Nepal. J Biosoc Sci 2006; 38: 57-67.
49. Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet 1995; 345: 1545.
50. Zwarenstein M, Schoeman J H, Vundule C, Lombard C J, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998; 352: 1340.
51. Jasmer R M, Seaman C B, Gonzalez L C, Kawamura L M, Osmond D H, Daley C L. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2004; 170: 561-566.
52. Littleton J, Park J, Thornley C, Anderson A, Lawrence J. Migrants and tuberculosis: analysing epidemiological data with ethnography. Aust NZ J Public Health 2008; 32: 142-149.
53. Park J, Littleton J. Ethnography plus' in tuberculosis research. SITES 2007; 4: 3-23.
54. Nichter M. Global Health: Why cultural perceptions, social representations, and biopolitics matter. Tucson, AZ, USA: University of Arizona Press, 2008.
55. Seeberg J. The event of DOTS and the transformation of the tuberculosis syndemic in India. Cambridge Anthropol 2014; 32: 95-113.
56. Goffman E. Stigma: notes on the management of spoiled identity. New York, NY, USA: Prentice Hall, 1963.
57. Williams S. Goffman, interactionism and the management of stigma in everyday life. In: Scrambler G, ed. Sociological theory and medical sociology. London, UK: Tavistock, 1987: pp 136-164.
58. Susman J. Disability, stigma and deviance. Soc Sci Med 1994; 38: 15-22.
59. Lambert M L, Van der Stuyft P. Delays to tuberculosis treatment: shall we continue to blame the victim? Trop Med Int Health 2005; 10: 945-946.
60. Edginton M, Sekatane C, Goldstein S. Patients' beliefs: do they affect tuberculosis control? A study in a rural district of South Africa. Int J Tuberc Lung Dis 2002; 6: 1075-1082.
61. Godfrey-Faussett P, Kaunda H, Kamanga J, et al. Why do patients with a cough delay seeking care at Lusaka urban health centres? A health systems research approach. Int J Tuberc Lung Dis 2002; 6: 796-805.
62. Liefooghe R, Baliddawa J, Kipruto E, Vermeire C, De Munynck A. From their own perspective. A Kenyan community's perception of tuberculosis. Trop Med Int Health 1997; 2: 809-821.
63. Douglas M. Purity and danger: an analysis of concept of pollution and taboo. London, UK and New York, NY, USA: Routledge, 2002.
64. Chambers M M. When is a moral taboo really formidable? J Educ Sociol 1960; 33: 342-345.
65. Heijnders M, Van Der Meij S. The fight against stigma: an overview of stigma-reduction strategies and interventions. Psychol Health Med 2006; 11: 353-363.
66. Karim F, Chowdhury A, Islam A, Weiss M G. Stigma, gender, and their impact on patients with tuberculosis in rural Bangladesh. Anthropol Med 2007; 14: 139-151.
67. Long N H, Johansson E, Diwan V K, Winkvist A. Different tuberculosis in men and women: beliefs from focus groups in Viet Nam. Soc Sci Med 1999; 49: 815-822.
68. Johansson E, Long N, Diwan V, Winkvist A. Gender and tuberculosis control: perspectives on health seeking behaviour among men and women in Viet Nam. Health Policy 2000; 52: 33-51.
69. Diwan V K, Thorson A. Sex, gender, and tuberculosis. Lancet 1999; 353: 1000-1001.
70. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013. http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf Accessed June 2015.
71. Weiss M G, Sommerfeld J, Uplekar M W. Social and cultural dimensions of gender and tuberculosis. Int J Tuberc Lung Dis 2008; 12: 829-830.
72. Ottmani S E, Uplekar M W. Gender and TB: pointers from routine records and reports. Int J Tuberc Lung Dis 2008; 12: 827-828.
73. Nair D M, George A, Chacko A K T. Tuberculosis in Bombay: new insights from poor urban patients. Health Policy Plan 1997; 12: 77-85.
74. Atre S, Kudale A, Morankar S, Gosoniu D, Weiss M G. Gender and community views of stigma and tuberculosis in rural Maharashtra, India. Glob Public Health 2011; 6: 56-71.
75. Goetz T. The remedy: Robert Koch, Arthur Conan Doyle and the quest to cure tuberculosis. New York, NY, USA: Gotham Books, 2014.
76. Bury M. Chronic illness as biographical disruption. Sociol Health Illn 1982; 4: 167-182.
77. Williams S J. Chronic illness as biographical disruption or biographical disruption as chronic illness? Reflections on a core concept. Sociol Health Illn 2000; 22: 40-67.
78. Bury M. Illness narratives: fact or fiction? Sociol Health Illn 2001; 23: 263-285.
79. Kleinman A. The illness narratives: suffering, healing and the human conditions. New York, NY, USA: Basic Books, 1988.
80. Ezzy D. Illness narratives: time, hope and HIV. Soc Sci Med 2000; 50: 605-617.
81. Whitehead L C. Quest, chaos and restitution: living with chronic fatigue syndrome/myalgic encephalomyelitis. Soc Sci Med 2006; 62: 2236-2245.
82. Kelly S. Stigma and silence: oral histories of tuberculosis. Oral History 2010; 39: 79-90.
83. Hacking I. Making up people. In: Biagioli M, ed. The science studies reader. New York, NY, USA: Routledge, 1999: pp 161-171.
84. Hacking I. The looping effects of human kinds. In: Sperber D, Premack D, Premack A J, eds. Causal cognition. New York, NY, USA: Clarendon Press, 1995: pp 351-394.
85. Nichter M. Harm reduction: a core concern for medical anthropology. In: Harthorn B H, Oaks L, eds. Risk, culture, and health inequality: shifting perceptions of danger and blame. Westport, CT, USA: Praeger, 2003: pp 13-33.
86. Lock M. Breast cancer: reading the omens. Anthropology Today 1998; 14: 7-16.
87. Coeckelbergh M. Human being @ risk: enhancement, technology and the evaluation of vulnerability transformations, philosophy of engineering and technology. Dordrecht, The Netherlands: Springer, 2013.
88. Mason P H. The liminal body: response to privacy in the context of 're-emergent' infectious diseases. J Bioeth Inq 2014; 11: 565-566.
89. Wolf S, Berle B B. The technological imperative in medicine: proceedings of a Totts Gap colloquium held June 15-17, 1980 at Totts Gap Medical Research Laboratories, Bangor, Pennsylvania. New York, NY, USA: Plenum Press, 1981.
90. Bhargava A, Pinto L, Pai M. Mismanagement of tuberculosis in India: causes, consequences, and the way forward. Hypothesis 2011; 9: e7.